Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-22-009002
Filing Date
2022-05-10
Accepted
2022-05-10 16:24:10
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 q1_2022_10q_-_pro_supp_n.htm 424B3 1855333
2 GRAPHIC img51554660_0.jpg GRAPHIC 33473
  Complete submission text file 0000950170-22-009002.txt   1902635
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

EIN.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-262339 | Film No.: 22910077
SIC: 2834 Pharmaceutical Preparations